胚胎移植日前后循环孕酮水平偏低女性接受孕酮补救治疗的有效性:系统综述与Meta分析
该系统综述与Meta分析纳入7项观察性研究共5927例患者,比较孕酮偏低(<10 ng/mL)接受补救孕酮与孕酮充足(≥10 ng/mL)者的妊娠结局。持续妊娠、临床妊娠、流产及活产结局均无显著差异,但作者指出需稳健的随机对照试验确认。
要点
- 孕酮偏低(<10 ng/mL)接受补救孕酮者持续妊娠率与孕酮充足(≥10 ng/mL)者无显著差异(OR 0.98)。
- 临床妊娠、流产及活产结局在两组间均无显著差异。
- 亚组分析按补救给药途径成功解释了汇总异质性。
核心结论
- 孕酮偏低患者接受补救孕酮后,持续妊娠率、临床妊娠率及活产率与孕酮充足者相当。
- 作者指出需稳健的随机对照试验评估孕酮偏低女性的补救治疗以确认这些发现。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南并在PROSPERO前瞻性注册(CRD42022357125)。
- 检索6个数据库(Embase、MEDLINE、APA PsycInfo、Global Health、HMIC、Google Scholar)及2个额外来源,检索时间自建库至2022年8月29日。
- 纳入报告补救孕酮与一项或多项妊娠结局关联的前瞻性和回顾性队列研究。
- 共纳入7项观察性研究,总计5927例患者,中位年龄34岁(四分位距[IQR]:31.55,37.13)。
- 采用纽卡斯尔-渥太华量表(NOS)评估纳入研究质量,采用GRADE框架评估证据质量。
主要发现
- 孕酮偏低(<10 ng/mL)接受补救剂量者 vs 孕酮充足(≥10 ng/mL)者,持续妊娠OR 0.98(95% CI:0.78,1.24;P=0.86,I²=41%)。
- 孕酮偏低接受补救剂量者 vs 孕酮充足者,流产OR 0.98(95% CI:0.81,1.17;P=0.80,I²=0)。
- 孕酮偏低接受补救剂量者 vs 孕酮充足者,临床妊娠OR 0.91(95% CI:0.78,1.06;P=0.24;I²=33%)。
- 孕酮偏低接受补救剂量者 vs 孕酮充足者,活产OR 0.92(95% CI:0.77,1.09;P=0.33;I²=43%)。
- 按补救给药途径进行的亚组分析成功解释了汇总异质性。
临床怎么用
- 作者认为,胚胎移植日前后循环孕酮偏低患者接受补救孕酮可能获得与孕酮充足者相当的生殖结局。
- 原文未据此给出推荐。
局限性
- 作者指出需稳健的随机对照试验评估孕酮偏低女性的补救治疗以确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Over the last decade, frozen embryo transfer (FET) has been increasingly used in contemporary fertility units. Despite the rapid increase in FET, there is still insufficient evidence to recommend an optimized protocol for endometrial preparation especially in patients with lower progesterone (P4) levels. Previous studies have concluded that P4 levels <10 ng/mL are associated with poorer pregnancy outcomes than those reported with high levels of circulating P4. OBJECTIVE: To identify whether rescue P4 dosing in patients with low P4 can salvage adverse outcomes associated with low P4 levels, resulting in outcomes comparable to patients with adequate progesterone. DATA SOURCES: The study was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-analyses guidelines and prospectively registered under the PROSPERO database (CRD42022357125). Six databases (Embase, MEDLINE, APA PsycInfo, Global Health, HMIC Health Management Information Consortium, and Google Scholar) and 2 additional sources were searched from inception to August 29, 2022. STUDY SELECTION AND SYNTHESIS: Prospective and retrospective cohort studies, reporting the association between rescue progesterone and one or more pregnancy outcomes, were included. The quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS), while the quality of evidence by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. Summative and subgroup data as well as heterogeneity were generated by the Cochrane platform RevMan (V. 5.4). MAIN OUTCOME MEASURE(S): To compare ongoing pregnancy rate as primary outcome and clinical pregnancy rate, miscarriage rate, and live birth rate as secondary outcomes between patients with low (<10 ng/mL) receiving rescue progesterone vs. those with adequate levels of P4 (≥10 ng/mL). RESULT(S): Overall, 7 observational studies were included in the analysis, with a total of 5927 patients of median age 34 (interquartile range [IQR]: 31.55, 37.13). Overall, patient group comparison, namely those with low P4 that received a rescue dose and those with adequate P4 levels, did not yield significant differences for either the primary or secondary outcomes. For ongoing clinical pregnancy, patients with low P4 receiving the rescue dose vs. those with adequate P4 levels was odds ratio (OR) 0.98 (95% CI: 0.78, 1.24; P = .86, I2: 41%), whereas for miscarriage events, OR was 0.98 (95% CI: 0.81, 1.17; P = .80, I2: 0). Equally, for clinical pregnancy, OR was 0.91 (95% CI: 0.78, 1.06; P = .24; I2: 33%), and for live birth, OR was 0.92 (95% CI: 0.77, 1.09; P = .33; I2: 43%). Subgroup analysis on the basis or rescue administration route successfully explained summative heterogeneity. CONCLUSION(S): Rescue P4 dosing in patients with low P4 results in ongoing pregnancy rate, clinical pregnancy and live birth rates were comparable to those of patients with adequate P4 levels. However, robust randomized controlled trials assessing rescue treatment in women with low P4 are needed to confirm these findings. Rescue P4 in patients with low circulating P4 around embryo transfer day may result in reproductive outcomes comparable to those with adequate P4 levels. STUDY REGISTRATION: CRD42022357125 (PROSPERO).
引用
- Stavridis K, Kastora SL, Triantafyllidou O, et al. Effectiveness of progesterone rescue in women presenting low circulating progesterone levels around the day of embryo transfer: a systematic review and meta-analysis. Fertil Steril. 2023. PMID: 36781098. doi:10.1016/j.fertnstert.2023.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。